Showing results (381-390 of 508) with videos related to
Sort By:
Pageof 51
Nature Medicine|August 1, 1997
Simian virus-40 large-T antigen binds p53 in human mesotheliomasM Carbone, P Rizzo, P M Grimley, et al.Cancer & Metabolism|August 4, 2021
Inflammatory metabolic profile of South African patients with prostate cancerStefano Cacciatore, Martha Wium, Cristina Licari, et al.Nature Medicine|January 3, 2001
Impaired prostate tumorigenesis in Egr1-deficient miceS A Abdulkadir, Z Qu, E Garabedian, et al.Oncogene|August 1, 1996
SV40-like sequences in human bone tumorsM Carbone, P Rizzo, A Procopio, et al.The Journal of Clinical Investigation|November 8, 2016
MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progressionCecilia Dallavalle, Domenico Albino, Gianluca Civenni, et al.Clinical and Diagnostic Laboratory Immunology|September 3, 1999
Detection of borna disease virus-reactive antibodies from patients with psychiatric disorders and from horses by electrochemiluminescence immunoassayK Yamaguchi, T Sawada, T Naraki, et al.Cancer Research|May 21, 2013
ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-κB and drives prostate cancer progressionNicole Longoni, Manuela Sarti, Domenico Albino, et al.Nature Communications|August 6, 2024
Epigenome-wide impact of MAT2A sustains the androgen-indifferent state and confers synthetic vulnerability in ERG fusion-positive prostate cancerAlessia Cacciatore, Dheeraj Shinde, Carola Musumeci, et al.Oncogene|February 15, 2012
The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progressionF Babbio, C Pistore, L Curti, et al.Nature Communications|July 7, 2021
EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancerMarita Zoma, Laura Curti, Dheeraj Shinde, et al.Pageof 51